Abstract:Abstract Objective To determine the analgesic effects of bone mesenchymal stem cells (BMSCs) transplantation on RTX induced neuropathic pain in mice and their potential mechanism related to microglia activation. Method A neuropathic pain model was induced by a single intraperitoneal injection of resiniferatoxin (RTX) in C57BL/6 mice. 1x106 GFP-labeled BMSCs were transplanted into the model mice through caudal vein injection, their analgesic potential was evaluated using behavioral tests. The activated microglial marker CD11b and p38 MAPK in the spinal cord were assessed by immunofluorescence and western blot. The dendritic spine profile changes and BMSCs tracings were also determined. Result Pain behavior induced by RTX showed significant hypersensitivity to nociceptive stimuli and lasted for 30 days with activation of microglia compared with control groups, the mechanical allodynia was significantly alleviated after grafts of BMSCs. Meanwhile, p38 MAPK protein level in the spinal cord were also significantly inhibited. RTX mice treated with BMSCs displayed positive immunofluorescence staining for GFP from BMSCs in the dorsal horn. Conclusions Systemic transplantation of BMSCs produce analgesic effect by reducing microglial activation and p38 MAPK level in RTX treated mice.